Osteosarcoma: Drugs

Health written question – answered at on 11 November 2010.

Alert me about debates like this

Photo of Anna Soubry Anna Soubry Conservative, Broxtowe

To ask the Secretary of State for Health what recent representations he has received on the decision by the National Institute of Health and Clinical Excellence not to recommend the introduction of mifamurtide into the NHS; and if he will make a statement.

Photo of Paul Burstow Paul Burstow The Minister of State, Department of Health

In the period 12 May 2010 to 5 November 2010, the Department received 116 written representations from hon. Members (including the hon. Lady's question), members of the public, a pharmaceutical company and patient groups about the National Institute for Health and Clinical Excellence's (NICE) ongoing appraisal of mifamurtide (Mepact) for the treatment of osteosarcoma. NICE has not yet issued its final guidance to the national health service.

Does this answer the above question?

Yes2 people think so

No2 people think not

Would you like to ask a question like this yourself? Use our Freedom of Information site.

Annotations

Andrew Turvey
Posted on 14 Nov 2010 10:59 pm (Report this annotation)

NICE issued a "final appraisal" - which was negative - on 8th October. The closing date for appeals was 22 October.

http://www.thepharmaletter.com/file/98933/uks-nice-rejects-u...

http://www.nice.org.uk/newsroom/pressreleases/DraftNICEGuida...

It seems a bit odd for the minister to hide behind a "no final decision has been made" defense - does that mean he will make a further reply when one has been made?